Gene transfer approaches to the lysosomal storage disorders

Area of Science:

• * Biomedical research
• * Genetic medicine
• * Lysosomal storage disorders

Background:

• * Lysosomal storage disorders (LSDs) are a group of rare genetic diseases.
• * Current treatments for LSDs are limited, necessitating novel therapeutic strategies.
• * Gene therapy offers a potential curative approach for these inherited conditions.

Purpose of the Study:

• * To develop and evaluate gene therapy strategies for lysosomal storage disorders.
• * To establish the preclinical foundation for a clinical trial in Gaucher disease.
• * To explore the potential application of gene transfer in other LSDs.

Main Methods:

• * Utilized animal and cell culture models to develop gene therapy vectors.
• * Conducted preclinical studies to assess gene transfer efficiency and safety.
• * Initiated and monitored a clinical trial involving gene transfer to hematopoietic stem cells (HSC).

Main Results:

• * Preclinical studies provided the scientific basis for clinical translation.
• * The ongoing clinical trial shows evidence of HSC transduction and engraftment.
• * Genetically corrected HSCs express the therapeutic transgene, with indications of a clinical response.

Conclusions:

• * Gene therapy targeting HSCs is a viable approach for Gaucher disease.
• * Clinical trials are demonstrating the feasibility and potential efficacy of this strategy.
• * The developed gene transfer methods may be applicable to other lysosomal storage disorders.